Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics
Maryam Omrani(Vita-Salute San Raffaele University), Cinthia Farina(Istituti di Ricovero e Cura a Carattere Scientifico), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Gloria Dalla Costa(Harvard University), Lucia Moiola(Vita-Salute San Raffaele University), Alessandra Protti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Francesca Sangalli(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University), Marco Puthenparampil(University of Padua), Simone Guerrieri(Vita-Salute San Raffaele University), Federico Montini(Mayo Clinic), Gıancarlo Comı(Casa di Cura Columbus), Claudia Bassani(Vita-Salute San Raffaele University), Roberto Bergamaschi(Jacobi Medical Center), Anna M. Pietroboni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), B Colombo(Vita-Salute San Raffaele University), Marzia Romeo(San Raffaele University of Rome), Massimo Acquaviva(Vita-Salute San Raffaele University), Maria A. Rocca(Vita-Salute San Raffaele University), Paolo Preziosa(Vita-Salute San Raffaele University), Rosaria Rita Chiarelli(Vita-Salute San Raffaele University), Francesca Grassivaro(University of Padua), Lucia Pagani(IQVIA (United Kingdom)), Massimo Filippi(Vita-Salute San Raffaele University)
Cited by 14
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k